Reblozyl User Reviews & Ratings
Reblozyl has an average rating of 10.0 out of 10 from a total of 4 reviews on Drugs.com. 100% of reviewers reported a positive experience, while 0% reported a negative experience.
| Condition | Avg. Rating | Reviews | Compare |
|---|---|---|---|
| Myelodysplastic Syndrome | 3 reviews for Myelodysplastic Syndrome | 5 medications | |
| Anemia | 1 reviews for Anemia | 190 medications | |
| Add your review | |||
- linkays
- Taken for 1 to 2 years
- February 24, 2023
For Anemia "I have sideroblastic anemia and my doctor tried many medicine to get my hemoglobin to an acceptable level. After my first shot of Reblozyl, my hemoglobin gave me good numbers. I have blood work done every 3 weeks and if my hemoglobin is below 11.5, I get a shot. If it's above 11.5, I do not. The last time I had a shot was 3 months ago but this week I had to get one. My doctor is very pleased with Reblozyl and so am I."
- Melody
- March 12, 2024
For Myelodysplastic Syndrome "This drug, when added to my treatment, gave me my life back. Only have to go to Moffitt for treatment every 12 weeks! No more blood transfusions or being hospitalized."
- Mark
- Taken for 1 to 6 months
- December 15, 2023
For Myelodysplastic Syndrome "The side effects are kicking my butt, but hemoglobin is going up with each 3-week shot! Received the 4th dose of shots but have no stamina at all!"
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
More about Reblozyl (luspatercept)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous erythropoiesis agents
- Breastfeeding
- En español
For Myelodysplastic Syndrome "Incredible results. Initially, the low dose was every 3 weeks, extended to 6 weeks with stable hemoglobin levels. Light side effects, although more nuanced after 7 months of the treatment, it seems. I am seeking information about the duration of the side effects and the possible increase over time."